Ironwood Pharmaceuticals | IRWD - Trade Creditors


Ironwood Pharmaceuticals reported $3.24M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 44.57M 32.32M Jun/2026
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Akebia Therapeutics USD 9.42M 1.04M Jun/2026
Almirall EUR 235.53M 22.52M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Amarin USD 18.8M 29.36M Jun/2026
Ardelyx USD 28.2M 8.96M Mar/2026
Astellas Pharma JPY 192.29B 7.47B Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Charles River Laboratories USD 140.98M 7.03M Jun/2026
Coherus Biosciences USD 13.17M 1.69M Jun/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
Halozyme Therapeutics USD 23.61M 9.51M Jun/2026
Incyte USD 1.39B 1.16B Jun/2026
Ironwood Pharmaceuticals USD 3.24M 339K Mar/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Lexicon Pharmaceuticals USD 3M 87K Mar/2026
MacroGenics USD 4.29M 500K Mar/2026
Moderna USD 167M 6M Jun/2026
Myriad Genetics USD 30.4M 2.2M Jun/2026
Pacira USD 17.51M 3.5M Jun/2026
PTC Therapeutics USD 40.45M 14.96M Jun/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Takeda JPY 446.78B 44.56B Jun/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
Vanda Pharmaceuticals USD 39.09M 33.28M Dec/2024